This randomized, crossover clinical trial showed that compared to isocaloric IOM, a high-protein, low-fat DSNS containing low-glycemic carbohydrates reduced postprandial glycemic response while increasing GLP-1 and insulin response in people with type 2 diabetes. This evidence concerns the gene GCG and type 2 diabetes mellitus.